Health

Can Viagra Help Heart-Diseased Men Live Longer?

Can Viagra Help Heart-Diseased Men Live Longer?

Those tiny blue tablets were created to support men who were suffering from impotence. However, based on the new Swedish studies, Viagra and similar drugs could reduce the threat of dying or having a new cardiac arrest in men with cardiovascular failure.


“Potency issues are popular in elderly men, and our research now indicates that PDE5 inhibition can protect toward heart attacks and extends life,” says Martin Holzmann, the report’s leading researcher. He serves as an adjunct instructor of pharmacy at Stockholm’s Karolinska College.

Can Viagra Help Heart-Diseased Men Live Longer?

According to the researchers, impotence has been attributed to reduced blood circulation and thus may be an early indicator of cardiovascular disease in active young men. This can be managed individually with the inserted drug alprostadil, or more generally, with PDE5 inhibitors, including medicines like Viagra & Cialis.

Can Viagra Help Heart-Diseased Men Live Longer?


Holzmann’s team analyzed the results of alprostadil and PDE5 antagonists in a community of 18,500 men who previously had a cardiac arrest and/or experienced an operation like bypass or heart surgery and were treated with “healthy” coronary artery disorder.


After six months from their cardiac arrest or heart operation, people in the research started using an erectile dysfunction medication. The majority of the men (approximately 16,500) took Cialis, Viagra, or another PDE5 inhibitor, while the others received administered alprostadil.


The men’s health was then monitored for a rate of eight-six years, during which time around 2,800 men expired. The Swedish group recorded March 22 in the Paper of the American School of Cardiology. Men using a PDE5 med would have a 12 percent smaller chance of death during the follow-up period than men receiving alprostadil.


PDE5 inhibitors have reduced the threat of a current cardiac arrest or the need for another angioplasty or bypass surgery in men compared to alprostadil. The benefit was daily dosage, suggesting the more often a PDE5 inhibitor was used, the smaller the man’s threat.

The pharmaceutical sector did not fund new research. According to a previous study by a similar group, men who had a cardiac arrest handle PDE5 medications well, and they can prolong life span and have beneficial results.
According to Holzmann, men with cardiac heart disease should never be afraid to discuss erectile disorder with their physicians.

The results are interesting, according to two experts in the U.S. who were not involved in the report. “It was not a treatment for any patients, with cardiac artery disorder only those who already have impotence,” Mintz clarified.
He also acknowledged that the impact has yet to be established.

“Additional research is required to determine if PDE5 inhibitors are wholly accountable for the positive results or whether the gain is related to getting a partner, enjoying a healthy sex life, or maintaining a better outlook on life.”


As per the Medical cardiology is directed by Dr. Michael Goyfman, he accepted whether the Swedish results are mainly helpful for generating hypotheses at this time, rather than changing medical practice.

He speculated that the positive results for men who took a PDE5 supplement could be due to their overall health or earnings. “While the research is intriguing, it is unlikely to affect practice until more randomized systematic trials are conducted.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top